###begin article-title 0
###xml 55 59 <span type="species:ncbi:10090">Mice</span>
Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor
###end article-title 0
###begin p 1
Conceived and designed the experiments: ECP NS JO. Performed the experiments: ECP TRC NS JO. Analyzed the data: ECP TRC JA NS JO. Contributed reagents/materials/analysis tools: JO. Wrote the paper: ECP NS JO.
###end p 1
###begin p 2
###xml 310 315 310 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 809 814 809 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 90 106 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 108 111 <span type="species:ncbi:40051">BTV</span>
###xml 234 237 <span type="species:ncbi:40051">BTV</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 343 346 <span type="species:ncbi:40051">BTV</span>
###xml 353 356 <span type="species:ncbi:40051">BTV</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 843 846 <span type="species:ncbi:40051">BTV</span>
###xml 925 928 <span type="species:ncbi:40051">BTV</span>
###xml 1035 1040 <span type="species:ncbi:10090">mouse</span>
###xml 1075 1078 <span type="species:ncbi:40051">BTV</span>
###xml 1143 1146 <span type="species:ncbi:40051">BTV</span>
Bluetongue (BT) is a noncontagious, insect-transmitted disease of ruminants caused by the bluetongue virus (BTV). A laboratory animal model would greatly facilitate the studies of pathogenesis, immune response and vaccination against BTV. Herein, we show that adult mice deficient in type I IFN receptor (IFNAR(-/-)) are highly susceptible to BTV-4 and BTV-8 infection when the virus is administered intravenously. Disease was characterized by ocular discharges and apathy, starting at 48 hours post-infection and quickly leading to animal death within 60 hours of inoculation. Infectious virus was recovered from the spleen, lung, thymus, and lymph nodes indicating a systemic infection. In addition, a lymphoid depletion in spleen, and severe pneumonia were observed in the infected mice. Furthermore, IFNAR(-/-) adult mice immunized with a BTV-4 inactivated vaccine showed the induction of neutralizing antibodies against BTV-4 and complete protection against challenge with a lethal dose of this virus. The data indicate that this mouse model may facilitate the study of BTV pathogenesis, and the development of new effective vaccines for BTV.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 240 250 240 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Culicoides</italic>
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Diptera</italic>
###xml 267 282 267 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ceratopogonidae</italic>
###xml 284 287 284 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Mellor1">[1]</xref>
###xml 602 605 602 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Barros1">[2]</xref>
###xml 607 610 607 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Breard1">[3]</xref>
###xml 612 615 612 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Mellor2">[4]</xref>
###xml 700 703 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Saegerman1">[5]</xref>
###xml 873 891 873 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Culicoides imicola</italic>
###xml 1003 1013 1003 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Culicoides</italic>
###xml 1015 1027 1015 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. obsoletus</italic>
###xml 1032 1044 1032 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. pulicaris</italic>
###xml 1047 1050 1047 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Purse1">[6]</xref>
###xml 88 104 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 106 109 <span type="species:ncbi:40051">BTV</span>
###xml 219 232 <span type="species:ncbi:198116">biting midges</span>
###xml 472 475 <span type="species:ncbi:40051">BTV</span>
###xml 510 513 <span type="species:ncbi:40051">BTV</span>
###xml 517 520 <span type="species:ncbi:40051">BTV</span>
###xml 524 527 <span type="species:ncbi:40051">BTV</span>
###xml 531 534 <span type="species:ncbi:40051">BTV</span>
###xml 542 545 <span type="species:ncbi:40051">BTV</span>
###xml 636 639 <span type="species:ncbi:40051">BTV</span>
###xml 873 891 <span type="species:ncbi:88399">Culicoides imicola</span>
###xml 1015 1027 <span type="species:ncbi:289301|species:ncbi:309006|species:ncbi:433029">C. obsoletus</span>
###xml 1032 1044 <span type="species:ncbi:234471|species:ncbi:177093">C. pulicaris</span>
Bluetongue (BT) is an infectious noncontagious viral disease of ruminants caused by the bluetongue virus (BTV). The virus, consisting of 24 different serotypes, is transmitted to its vertebrate host by a few species of biting midges of the Culicoides genus (Diptera: Ceratopogonidae) [1]. BT is a reportable disease of considerable socioeconomic concern and of major importance in the international trade of animals and animal products. From 1998 through 2005, at least 6 BTV strains belonging to 5 serotypes (BTV-1, BTV-2, BTV-4, BTV-9, and BTV-16) were continously present in the Mediterranean Basin [2], [3], [4]. Since August 2006, BTV-8 has caused severe epizootic outbreakes in northern Europe [5]. The emergence of BT in parts of Europe never before affected was attributed mainly to climate change and linked to the Northern expansion of the major Old World vector Culicoides imicola. Additionally, there is also evidence for the involvement of other novel indigenous European vector species of Culicoides (C. obsoletus and C. pulicaris ) [6].
###end p 4
###begin p 5
###xml 131 140 131 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orbivirus</italic>
###xml 159 169 159 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reoviridae</italic>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Mertens1">[7]</xref>
###xml 593 596 593 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-DeMaula1">[8]</xref>
###xml 850 853 850 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Verwoerd1">[9]</xref>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Verwoerd2">[10]</xref>
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
###xml 178 181 <span type="species:ncbi:40051">BTV</span>
###xml 499 502 <span type="species:ncbi:40051">BTV</span>
BTV has a genome composed of ten linear segments of double-stranded RNA (dsRNA) and is classified as the type species of the genus Orbivirus within the family Reoviridae[7]. The BTV genome encodes 7 structural (VP1 through VP7) and 4 nonstructural proteins (NS1 through NS3/NS3A). The outer capsid is composed of two major structural proteins, VP2 and VP5 (segments 2 and 6, respectively), involved in cell attachment and virus entry. VP2 is known to contain the major neutralization determinant of BTV while VP5 influences virus neutralization through its conformational interaction with VP2 [8]. The outer capsid covers the inner capsid that is composed of two major structural proteins VP3 and VP7 (encoded by segments 3 and 7, respectively) and three distinct minor proteins (VP1, VP4, and VP6 corresponding to segments 1, 4, and 9 respectively) [9], in addition to the viral genome. Four other nonstructural proteins, produced during the viral cycle (NS1, NS2, and NS3/NS3A) (segments 6, 8, and 10 respectively), are more conserved among serotypes [10].
###end p 5
###begin p 6
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Brewer1">[11]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Letchworth1">[12]</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Carr1">[13]</xref>
###xml 39 42 <span type="species:ncbi:40051">BTV</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 349 352 <span type="species:ncbi:40051">BTV</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
###xml 505 508 <span type="species:ncbi:40051">BTV</span>
Studies involving the natural hosts of BTV are limited by the complexity of the system, the scarce knowledge of their immune system, and the need to have an animal facility with biosafety level 3. To circumvent some of these problems, an adequate system would be the use of adult mice because of the knowledge of its genetics and its manageability. BTV infects newborn mice [11], [12], [13], but an adult mouse model will be necessary to allow studies of acquired immune responses and vaccination against BTV.
###end p 6
###begin p 7
###xml 66 70 62 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Jameson1">[14]</xref>
###xml 72 76 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Fulton1">[15]</xref>
###xml 78 82 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-MacLachlan1">[16]</xref>
###xml 288 292 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Foster1">[17]</xref>
###xml 976 980 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Schindler1">[18]</xref>
###xml 982 986 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Staeheli1">[19]</xref>
###xml 988 992 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Muller1">[20]</xref>
###xml 994 998 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Sen1">[21]</xref>
###xml 1203 1208 1174 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1388 1392 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Muller1">[20]</xref>
###xml 1394 1398 1365 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Fiette1">[22]</xref>
###xml 1429 1433 1400 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-IdaHosonuma1">[23]</xref>
###xml 1488 1493 1459 1464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1869 1874 1826 1831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 2084 2088 2041 2045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Ohka1">[24]</xref>
###xml 2090 2094 2047 2051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Ohno1">[25]</xref>
###xml 2096 2100 2053 2057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Bouloy1">[26]</xref>
###xml 2102 2106 2059 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Waibler1">[27]</xref>
###xml 2192 2196 2149 2153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Muller1">[20]</xref>
###xml 2198 2202 2155 2159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Fiette1">[22]</xref>
###xml 2221 2226 2178 2183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 0 16 <span type="species:ncbi:40051">Bluetongue virus</span>
###xml 181 186 <span type="species:ncbi:9940">sheep</span>
###xml 201 204 <span type="species:ncbi:40051">BTV</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1209 1213 <span type="species:ncbi:10090">mice</span>
###xml 1494 1498 <span type="species:ncbi:10090">mice</span>
###xml 1641 1651 <span type="species:ncbi:138953">poliovirus</span>
###xml 1875 1879 <span type="species:ncbi:10090">mice</span>
###xml 1989 2010 <span type="species:ncbi:126794">vaccinia virus Ankara</span>
###xml 2025 2038 <span type="species:ncbi:11234">measles virus</span>
###xml 2068 2083 <span type="species:ncbi:11082">West Nile virus</span>
###xml 2187 2191 <span type="species:ncbi:10090">mice</span>
###xml 2227 2231 <span type="species:ncbi:10090">mice</span>
###xml 2270 2273 <span type="species:ncbi:40051">BTV</span>
Bluetongue virus is a potent interferon alpha (IFN-alpha) inducer [14], [15], [16]. In addition, a temporal relationship between viremia and IFN-alpha activity has been observed in sheep infected with BTV, where IFN peak concentrations induced approximately a 90% decrease in virus titer [17]. IFN-alpha plays an essential role in the antiviral innate immune response. Virus-derived dsRNAs are detected by Toll-like receptors on type I IFN-producing cells (mostly notably on plasmacytoid dendritic cells). Secreted IFNs bind to the type I IFN receptor (IFNAR) on the surface of neighbouring cells, activating the Janus kinase (Jak)/signal transducer and activator of transcription (Stat) signalling pathway. This in turn induces the transcriptional activation of target genes, the products of which render the cells resistant to virus replication through various mechanisms, including degradation of viral mRNAs, inhibition of viral translation, and inhibition of cell growth [18], [19], [20], [21]. Blocking IFN-alpha/beta activity in mice leads to a dramatically increased sensitivity to many viruses. Genetically targeted (knockout) mice lacking the beta subunit of the IFN-alpha/beta receptor (IFNAR(-/-) mice) are unable to establish an antiviral state and, as a consequence, are highly susceptible to many viral infections, despite the presence of an otherwise intact immune system [20], [22]. Recently, Ida-Hosonuma et al [23] found that the deletion of the IFNAR gene in the IFNAR(-/-) mice resulted in the disruption of IFN- alpha/beta-induced signaling, which is an important determinant of the tissue tropism and pathogenicity of poliovirus. Similarly, it has been reported that IFN- alpha/beta plays an important role in the pathogenicity and tissue tropism of some viruses. The lack of an IFN system allows the virus to replicate more efficiently and IFNAR(-/-) mice have been used as a laboratory animal model to study the immune response and pathogenicity of coronaviruses, vaccinia virus Ankara strain (MVA), measles virus, Rift valley fever virus and West Nile virus [24], [25], [26], [27]. All these data, and the presence of an otherwise intact immune system in these mice [20], [22] suggest that IFNAR(-/-) mice could be a good animal model to study BTV infections and to evaluate vaccine strategies against this virus.
###end p 7
###begin p 8
###xml 145 150 145 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 340 345 340 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 436 441 436 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 129 132 <span type="species:ncbi:40051">BTV</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 186 189 <span type="species:ncbi:40051">BTV</span>
###xml 223 226 <span type="species:ncbi:40051">BTV</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:9913">calf</span>
###xml 400 405 <span type="species:ncbi:9940">sheep</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 465 468 <span type="species:ncbi:40051">BTV</span>
###xml 541 544 <span type="species:ncbi:40051">BTV</span>
Here, we report the establishment of a new laboratory animal model suitable for the evaluation of vaccination strategies against BTV. Adult IFNAR(-/-) mice support the in vivo growth of BTV-4 after intravenous inoculation. BTV-4 replicated in spleen, lung, thymus, and lymph nodes (popliteal, inguinal, mediastinal, and mesenteric) of IFNAR(-/-) mice reproducing the tropism observed during calf and sheep infections. In addition, IFNAR(-/-) mice vaccinated with a BTV-4 inactivated vaccine show complete protection against a lethal dose of BTV-4
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 46 51 46 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
BTV-4 causes a lethal infection in adult IFNAR(-/-) mice
###end title 10
###begin p 11
###xml 148 153 148 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 264 269 264 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 479 484 479 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 527 534 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g001">Fig. 1A</xref>
###xml 693 695 693 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 785 787 785 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2.6</sup>
###xml 808 815 808 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g001">Fig. 1B</xref>
###xml 845 846 845 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 29 35 <span type="species:ncbi:10090">murine</span>
###xml 46 49 <span type="species:ncbi:40051">BTV</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 162 165 <span type="species:ncbi:40051">BTV</span>
###xml 213 216 <span type="species:ncbi:40051">BTV</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 348 351 <span type="species:ncbi:40051">BTV</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 510 513 <span type="species:ncbi:40051">BTV</span>
###xml 761 764 <span type="species:ncbi:40051">BTV</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
In order to develop an adult murine model for BTV infection in which mice showed disease symptoms, we tested the susceptibility of C57BL/6 and IFNAR(-/-) mice to BTV infection. Since blood is the natural route of BTV infection in ruminants, adult C57BL/6 and IFNAR(-/-) mice (males, 8 weeks old) were infected intravenously (i.v.) with 106 PFUs of BTV-4. Under these conditions, C57BL/6 mice did not show any disease symptom or death following viral infection. By contrast, IFNAR(-/-) mice were susceptible to BTV-4 infection (Fig. 1A), showing disease symptoms characterized by ocular discharges and apathy starting at 48 h.p.i. Disease progression led to animal death within 60 h.p.i. The LD50 value was obtained by i.v. inoculation with 10-fold dilutions of BTV-4, resulting in a LD50 value of 102.6 PFU (Fig. 1B). At low infectious doses (102 PFU or less) mice survived up to 21 days, at which point the experiment was terminated (data not shown).
###end p 11
###begin title 12
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 32 35 <span type="species:ncbi:40051">BTV</span>
Susceptibility of adult mice to BTV-4 infection.
###end title 12
###begin p 13
###xml 21 26 21 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 227 232 227 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 111 114 <span type="species:ncbi:40051">BTV</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 261 264 <span type="species:ncbi:40051">BTV</span>
###xml 268 272 <span type="species:ncbi:10090">Mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 361 364 <span type="species:ncbi:40051">BTV</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
(A) C57BL/6 and IFNAR(-/-) mice (8 weeks old, 6 mice per group) were intravenously inoculated with 106 PFUs of BTV-4. The mice were observed every 12 h for the first 3 days and every 24 h for 7 days. (B) Survival rates of IFNAR(-/-) mice after inoculation with BTV-4. Mice (8 weeks old, 6 mice per group) were intravenously inoculated with 10-fold dilutions of BTV-4. The number of PFUs inoculated is indicated on each survival group. The mice were observed every 24 h for 7 days.
###end p 13
###begin p 14
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 257 262 257 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 293 300 293 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g002">Fig. 2A</xref>
###xml 327 328 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 394 399 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 660 667 660 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g002">Fig. 2B</xref>
###xml 732 733 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 819 820 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 981 982 981 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 104 107 <span type="species:ncbi:40051">BTV</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 865 868 <span type="species:ncbi:40051">BTV</span>
###xml 993 996 <span type="species:ncbi:40051">BTV</span>
To determine virus dissemination, viral titers in blood samples after i.v. inoculation with 104 PFUs of BTV-4 were analyzed. According to the previous data, no viremia was detected in C57BL/6 mice (data not shown). In contrast, viremia was observed in IFNAR(-/-) mice at day 2 post-infection (Fig. 2A), with peak titers of 5x104 PFU/ml at day 4 post-infection (p.i.), before animal death. IFNAR(-/-) mice inoculated with 102 PFU did not show any viremia but titers up to 3x104 PFU/ml were observed at 3 and 4 days p.i. in mice inoculated with 103 PFUs. Viral spread was determined in tissue samples. The first tissue to be reached by the virus was the spleen (Fig. 2B) where infectious virus was detected as early as 24 h.p.i. (5x103 PFU/gr), with viral titers increasing thereafter until death (reaching titers of 2x106 PFU/gr). By 48 h.p.i. significant titers of BTV-4 were detected in spleen, lung, thymus, and popliteal and mesenteric lymph nodes. At 72 h.p.i., titers up to 106 PFU/gr of BTV-4 were recovered from the spleen, lung, thymus, and lymph nodes (popliteal, inguinal, mediastinal and mesenteric). No infectious virus was detected in liver, brain, heart, tongue, skin, and testicles at any time points examined, even when the tissues were analyzed by RT-PCR (data not shown). Interestingly, the virus was not detected in the blood until 48 h.p.i. These results suggest that the virus leaks into the blood stream after replicating in the spleen.
###end p 14
###begin title 15
###xml 58 63 58 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
BTV-4 titers in blood and several organs of infected IFNAR(-/-) mice.
###end title 15
###begin p 16
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 109 110 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 120 121 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 216 237 177 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 439 440 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 621 642 582 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and methods</xref>
###xml 14 17 <span type="species:ncbi:40051">BTV</span>
###xml 147 150 <span type="species:ncbi:40051">BTV</span>
###xml 365 369 <span type="species:ncbi:10090">Mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 449 452 <span type="species:ncbi:40051">BTV</span>
(A) Titers of BTV-4 recovered in blood after intravenous infection with 102 (blacksquare, square, filled), 103(*), or 104 (black triangle) PFUs of BTV-4. Virus was extracted from blood and determined as described in Materials and Methods. Each point represents the mean values of the viral titer of six animals, and standard deviations are shown as error bars. (B) Mice (8 weeks old, 6 mice per group) were inoculated intravenously with 104 PFUs of BTV-4. Virus was extracted from the indicated tissues at 24, 48 and 72 hours after infection for virus titration. Standard deviations are given. Procedures are detailed in Materials and methods.
###end p 16
###begin title 17
###xml 23 28 23 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 43 46 <span type="species:ncbi:40051">BTV</span>
Susceptibility of IFNAR(-/-) mice to other BTV serotypes
###end title 17
###begin p 18
###xml 26 31 26 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 90 95 90 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 390 397 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g003">Fig. 3A</xref>
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g001">Fig. 1B</xref>
###xml 548 555 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g003">Fig. 3B</xref>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 723 724 723 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 791 792 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 799 800 799 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 975 980 975 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1167 1172 1167 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 57 60 <span type="species:ncbi:40051">BTV</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 151 154 <span type="species:ncbi:40051">BTV</span>
###xml 158 162 <span type="species:ncbi:10090">Mice</span>
###xml 269 272 <span type="species:ncbi:40051">BTV</span>
###xml 304 307 <span type="species:ncbi:40051">BTV</span>
###xml 331 334 <span type="species:ncbi:40051">BTV</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 406 409 <span type="species:ncbi:40051">BTV</span>
###xml 541 544 <span type="species:ncbi:40051">BTV</span>
###xml 558 561 <span type="species:ncbi:40051">BTV</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 926 929 <span type="species:ncbi:40051">BTV</span>
###xml 961 964 <span type="species:ncbi:40051">BTV</span>
###xml 981 985 <span type="species:ncbi:10090">mice</span>
###xml 987 990 <span type="species:ncbi:40051">BTV</span>
###xml 997 1000 <span type="species:ncbi:40051">BTV</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1258 1261 <span type="species:ncbi:40051">BTV</span>
To determine whether IFNAR(-/-) mice were susceptible to BTV of different serotypes, IFNAR(-/-) mice were inoculated with ten-fold serial dilutions of BTV-8. Mice infected with serotype 8 showed similar symptoms to those shown after infection with serotype 4. However, BTV-8 showed higher virulence than BTV-4 with only 10 PFUs of BTV-8 being enough to kill 100% of the mice at day 7 p.i. (Fig. 3A), while BTV-4 was not lethal at the same infective dose (Fig. 1B). The viremia was determined after i.v. inoculation with 10-fold dilutions of BTV-8 (Fig. 3B). BTV-8 was first detected in blood of mice inoculated with 10 PFUs at day 4 post-infection, and the titer increased up to 2x104 PFU/ml at day 5 p.i. Titers up to 8x103 PFU/ml were observed at 3 and 4 days p.i. in mice infected with 103 and 102 PFUs, respectively. In the three dilutions of virus analyzed, viral titers increased thereafter until animal death. Although BTV-8 showed higher virulence than BTV-4 in IFNAR(-/-) mice, BTV-8 and BTV-4 titers in blood were equivalent, indicating that the higher virulence of serotype 8 is not due to a higher level of viral replication. These data suggest that IFNAR(-/-) mice could be an adequate small animal model to study differences in virulence among BTV serotypes.
###end p 18
###begin title 19
###xml 23 28 23 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 83 86 <span type="species:ncbi:40051">BTV</span>
Survival rates of IFNAR(-/-) mice and virus titers in blood after inoculation with BTV-8.
###end title 19
###begin p 20
###xml 448 469 448 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 97 100 <span type="species:ncbi:40051">BTV</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 231 234 <span type="species:ncbi:40051">BTV</span>
###xml 312 315 <span type="species:ncbi:40051">BTV</span>
(A) Mice (8 weeks old, 6 mice per group) were intravenously inoculated with 10-fold dilutions of BTV-8. The number of PFUs inoculated is indicated on each survival group. The mice were observed every 24 h for 7 days. (B) Titers of BTV-8 recovered in blood after intravenously infection with 10-fold dilutions of BTV-4. The number of PFUs inoculated is indicated on each survival group. Virus was extracted from blood and determined as described in Materials and Methods. Each point represents the mean values of the viral titer of six animals, and standard deviations are shown as error bars.
###end p 20
###begin title 21
###xml 24 29 24 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
BTV-4 infection of IFNAR(-/-) adult mice causes microscopic lesions in several tissues
###end title 21
###begin p 22
###xml 211 216 211 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 568 574 568 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g004">Fig. 4</xref>
###xml 672 678 672 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g004">Fig. 4</xref>
###xml 1037 1043 1037 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g004">Fig. 4</xref>
###xml 1295 1300 1295 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 80 83 <span type="species:ncbi:40051">BTV</span>
###xml 178 181 <span type="species:ncbi:40051">BTV</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 426 429 <span type="species:ncbi:40051">BTV</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 1249 1252 <span type="species:ncbi:40051">BTV</span>
###xml 1301 1305 <span type="species:ncbi:10090">mice</span>
In order to study the pathological effects of the infection in the organs where BTV replicates, histological analysis were performed on material of several organs extracted from BTV infected and uninfected IFNAR(-/-) mice at 48 h.p.i. Gross pathological alterations were characterized by widespread oedema, haemorrhages especially in spleen and lungs, and enlarged spleen and lymph nodes. Histological examination of lungs of BTV infected mice showed hyperemia and increased septum size with infiltration of lymphocytes, inactivated macrophages and a few neutrophils (Fig. 4). The peribronchial and perivascular connective tissue contained a few infiltrating round cells (Fig. 4). These histopathological findings are consistent with bronchointerstitial pneumonia. There was also a moderate oedema in the alveolar cavity with presence of abundant alveolar macrophages and a few detached epithelial cells (descamative alveolitis). The infected spleen showed a marked lymphoid depletion with infiltration of neutrophils in the white pulp (Fig. 4). This lymphoid depletion was also observed in the thymus as well as the loss of thymic architecture with the medulla and the cortex becoming not distinguishable (data not shown). The results suggest that BTV-4 produces similar tissue lesions in IFNAR(-/-) mice than in the natural host.
###end p 22
###begin title 23
###xml 66 71 66 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 40 43 <span type="species:ncbi:40051">BTV</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Tissue sections of lung and spleen from BTV-4 infected adult IFNAR(-/-) mice.
###end title 23
###begin p 24
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 36 39 <span type="species:ncbi:40051">BTV</span>
###xml 145 148 <span type="species:ncbi:40051">BTV</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 255 258 <span type="species:ncbi:40051">BTV</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
Mice were infected with 103 PFUs of BTV-4 intravenously. Tissues were harvested at 48 h.p.i.. Hematoxylin and eosin staining are shown. Lungs of BTV-infected mice show hyperemia and increased size of the interalveolar septa (100x). The spleen sections of BTV-infected mice show loss of architectural structure and marked lymphoid depletion (100x).
###end p 24
###begin title 25
###xml 15 20 15 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 68 71 <span type="species:ncbi:40051">BTV</span>
Immunized IFNAR(-/-) mice are completely protected against a lethal BTV-4 challenge
###end title 25
###begin p 26
###xml 83 88 83 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 211 216 211 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 337 342 337 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 517 519 517 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 712 719 712 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g005">Fig. 5A</xref>
###xml 843 848 843 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 985 990 983 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1033 1034 1031 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1160 1167 1158 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g005">Fig. 5B</xref>
###xml 1256 1261 1254 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1323 1330 1321 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005171-g005">Fig. 5C</xref>
###xml 1426 1427 1424 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1597 1602 1595 1600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1661 1668 1659 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005171-t001">Table 1</xref>
###xml 1770 1771 1768 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1796 1797 1794 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1992 1993 1990 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 2062 2063 2058 2059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2136 2137 2132 2133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2188 2189 2184 2185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2487 2492 2483 2488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 37 40 <span type="species:ncbi:40051">BTV</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 125 128 <span type="species:ncbi:40051">BTV</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 250 253 <span type="species:ncbi:40051">BTV</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 377 380 <span type="species:ncbi:40051">BTV</span>
###xml 395 398 <span type="species:ncbi:40051">BTV</span>
###xml 523 526 <span type="species:ncbi:40051">BTV</span>
###xml 829 832 <span type="species:ncbi:40051">BTV</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1043 1046 <span type="species:ncbi:40051">BTV</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
###xml 1316 1319 <span type="species:ncbi:40051">BTV</span>
###xml 1382 1386 <span type="species:ncbi:10090">mice</span>
###xml 1536 1539 <span type="species:ncbi:40051">BTV</span>
###xml 1603 1607 <span type="species:ncbi:10090">mice</span>
###xml 1624 1627 <span type="species:ncbi:40051">BTV</span>
###xml 1670 1673 <span type="species:ncbi:40051">BTV</span>
###xml 1720 1724 <span type="species:ncbi:10090">mice</span>
###xml 1754 1757 <span type="species:ncbi:40051">BTV</span>
###xml 1942 1946 <span type="species:ncbi:10090">mice</span>
###xml 2055 2059 <span type="species:ncbi:10090">mice</span>
###xml 2178 2182 <span type="species:ncbi:10090">mice</span>
###xml 2226 2230 <span type="species:ncbi:10090">mice</span>
###xml 2251 2254 <span type="species:ncbi:40051">BTV</span>
###xml 2422 2425 <span type="species:ncbi:40051">BTV</span>
###xml 2493 2497 <span type="species:ncbi:10090">mice</span>
All the previous data indicated that BTV-4 caused a lethal infection in adult IFNAR(-/-) mice. To provide further proof that BTV-4 was the causative agent of the disease and death in these animals and that IFNAR(-/-) mice are a good animal model for BTV vaccination studies, vaccination protection experiments were performed. Adult IFNAR(-/-) mice were immunized with a ZULVAC-BTV-4 inactivated BTV-4 preparation. The vaccine was administered by two consecutive subcutaneous injections of the equivalent to 3x105 TCID50 of BTV-4 at 3 weeks intervals. After the second immunization, VP2 antibody titers were determined by ELISA. All immunized animals, but not the control animals, developed an antibody response (Fig. 5A) indicating a successful immunization. In addition, the immunization induced neutralizing antibodies against BTV-4 in IFNAR(-/-) mice (VNT 1.53+/-0.32) as detected by virus neutralization tests. Three weeks after the second immunization, immunized and control IFNAR(-/-) mice were challenged intravenously with 103 PFUs of BTV-4. While all nonimmunized animals died, 100% of the immunized animals were protected against a lethal challenge (Fig. 5B). Infectious viral titers were analyzed in the blood of immunized and nonimmunized IFNAR(-/-) mice by plaque assay after intravenous infection with BTV-4 (Fig. 5C). No Infectious viruses were detected in immunized mice; however, we observed titers up to 3x104 PFU/ml in nonimmunized animals at day 5 post-challenge. In addition, we analyzed by RT-qPCR the presence of BTV genomes in the blood of inmmunized and nonimmunized IFNAR(-/-) mice challenged with BTV-4. The results are summarized in Table 1. BTV genomes were readily detected in nonimmunized mice at days three and four after BTV infection (Ct: 27-29) and increased (Ct: 23-26) thereafter until the death of the animal. In contrast, the RT-qPCR reaction yield no positive results for the majority of the immunized mice (n = 5) at all days post-challenge analyzed (Ct>/=38). Viral genomes were detected in one of the vaccinated mice (Ct: 30) at days four and five post-challenge and in two of them at day 5 (Ct: 32). However, in these three immunized mice the Ct was higher than in the nonimmunized mice and the presence of BTV-genomes reverted to negative at day 7 post-challenge. Overall, these data indicate that protective immunity was achieved after vaccination. These results confirm that BTV-4 was the causative agent of disease and death of adult IFNAR(-/-) mice.
###end p 26
###begin title 27
###xml 30 35 30 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 58 61 <span type="species:ncbi:40051">BTV</span>
Protection of vaccinated IFNAR(-/-) mice against a lethal BTV-4 challenge.
###end title 27
###begin p 28
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 247 252 247 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 391 412 391 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 468 473 468 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 630 635 630 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 731 752 731 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 102 105 <span type="species:ncbi:40051">BTV</span>
###xml 148 151 <span type="species:ncbi:40051">BTV</span>
###xml 193 196 <span type="species:ncbi:40051">BTV</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 314 317 <span type="species:ncbi:40051">BTV</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 502 505 <span type="species:ncbi:40051">BTV</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 570 573 <span type="species:ncbi:40051">BTV</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 662 665 <span type="species:ncbi:40051">BTV</span>
Mice (8 weeks old, 8 per group) were immunized twice by subcutaneous administration of an inactivated BTV-4 vaccine and inoculated with 103 PFUs of BTV-4,. (A) ELISA detection of antibodies to BTV-4 VP2 in serum of immunized and nonimmunized IFNAR(-/-) mice. Serum was collected two days before the challenge with BTV-4, and dilutions (1:50 to 1:1350) were analyzed by ELISA as described in Materials and Methods. (B) Survival rates of immunized and nonimmunized IFNAR(-/-) mice after inoculation with BTV-4. The mice were observed every 24 h for 14 days. (C) Titers of BTV-4 recovered in blood of immunized and nonimmunized IFNAR(-/-) mice after challenge with BTV-4. Virus was extracted from blood and determined as described in Materials and Methods. Each point represents the mean values of the viral titer of eight animals, and standard deviations are shown as error bars.
###end p 28
###begin title 29
###xml 63 68 63 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 13 16 <span type="species:ncbi:40051">BTV</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 95 98 <span type="species:ncbi:40051">BTV</span>
Detection of BTV-4 in blood of immunized and nonimmunized IFNAR(-/-) mice after challenge with BTV-4 by RT-qPCR_S5.
###end title 29
###begin p 30
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
Results expressed as Ct and transferred to negative (neg.) according to the cut-off Ct>/=38 described by Toussaint et al. (2007).
###end p 30
###begin p 31
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
I, immunized mice. C, nonimmunized mice.
###end p 31
###begin p 32
###xml 8 12 <span type="species:ncbi:10090">mice</span>
, death mice.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 365 370 365 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 161 164 <span type="species:ncbi:40051">BTV</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 411 414 <span type="species:ncbi:40051">BTV</span>
###xml 421 424 <span type="species:ncbi:40051">BTV</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 703 706 <span type="species:ncbi:40051">BTV</span>
###xml 856 861 <span type="species:ncbi:10090">mouse</span>
###xml 885 888 <span type="species:ncbi:40051">BTV</span>
For years, different groups have tried to establish a laboratory animal model to facilitate the studies of pathogenesis, immune response and vaccination against BTV. Natural hosts, although excellent tools for studies of pathogenesis and vaccination, are expensive and required specialized laboratories. Here, we characterize a new animal model based on adult IFNAR(-/-) mice that support the in vivo growth of BTV-4 and BTV-8 after intravenous inoculation. A tremendous advantage of this mouse model is the availability of a wide variety of reagents that can be used to study many aspects of the immune response to the virus. In addition, we propose this animal model as an adequate system for testing BTV vaccines, an important issue because the cost of testing new vaccines in target species is a major obstacle for laboratories and industries. The new mouse model for the study of BTV infection has unique features that open the possibility to study in the same host-virus system susceptibility, virulence, immunobiology of infection, and vaccine efficacy, in ways that are not approachable with the natural host.
###end p 34
###begin p 35
###xml 25 29 25 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Brewer1">[11]</xref>
###xml 31 35 31 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Letchworth1">[12]</xref>
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Carr1">[13]</xref>
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Franchi1">[28]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Jones1">[29]</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Narayan1">[30]</xref>
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 163 166 <span type="species:ncbi:40051">BTV</span>
###xml 279 282 <span type="species:ncbi:40051">BTV</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 422 436 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 489 492 <span type="species:ncbi:40051">BTV</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 573 576 <span type="species:ncbi:40051">BTV</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 670 673 <span type="species:ncbi:40051">BTV</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1246 1250 <span type="species:ncbi:10090">mice</span>
###xml 1265 1268 <span type="species:ncbi:40051">BTV</span>
###xml 1348 1353 <span type="species:ncbi:10090">mouse</span>
###xml 1433 1436 <span type="species:ncbi:40051">BTV</span>
BTV infects newborn mice [11], [12], [13], [28], but an adult animal model will be necessary to allow studies of acquired immune responses and vaccination against BTV. Different approaches have been followed to avoid this problem. The protective effects of baculovirus expressed BTV-10 minor and non-structural proteins were assessed by measuring virus titers in the ovaries of mice challenged with homologous recombinant vaccinia virus (rVV). Protection mediated by CTLs specific for the BTV minor or nonstructural proteins could not be evaluated by challenging mice with BTV-10, as the virus does not cause disease in adult mice [29]. The infection of fetal mice with BTV leads to severe cerebral malformation. Infection of 2-week-old mice resulted in very limited multiplication without sequelae, and infection of 4-week-old mice did not show clinical disease and no viral multiplication was detected [30]. Thus, the use of highly immature mice results in pathologies that do not resemble those found in the natural host. Another aspect to consider is the route of inoculation that may determine the outcome of infection. In this work, we have used the intravenous inoculation to resemble the natural infection route by mosquito biting. Thus, mice infected with BTV i.v. develop clinical symptoms, as it happens in natural hosts. This makes the mouse model even more atractive to be used as a tool for studying immune response to BTV and vaccination strategies.
###end p 35
###begin p 36
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Ohka1">[24]</xref>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Mrkic1">[31]</xref>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Jameson1">[14]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-MacLachlan1">[16]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Jameson2">[32]</xref>
###xml 748 753 748 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 888 893 888 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1005 1010 1005 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1201 1202 1201 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1277 1282 1277 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1615 1618 1615 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Saegerman1">[5]</xref>
###xml 1720 1725 1720 1725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1820 1821 1820 1821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 2104 2109 2104 2109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 2206 2211 2206 2211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 2386 2390 2386 2390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-MacLachlan2">[33]</xref>
###xml 2392 2396 2392 2396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-BarrattBoyes1">[34]</xref>
###xml 2406 2411 2406 2411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 2772 2776 2772 2776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-BarrattBoyes1">[34]</xref>
###xml 2828 2833 2828 2833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 3037 3041 3037 3041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-SchwartzCornill1">[35]</xref>
###xml 3623 3628 3623 3628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 492 505 <span type="species:ncbi:11234">measles virus</span>
###xml 552 557 <span type="species:ncbi:10090">mouse</span>
###xml 620 623 <span type="species:ncbi:40051">BTV</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 674 680 <span type="species:ncbi:9913">cattle</span>
###xml 721 724 <span type="species:ncbi:40051">BTV</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
###xml 932 935 <span type="species:ncbi:40051">BTV</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1030 1033 <span type="species:ncbi:40051">BTV</span>
###xml 1096 1100 <span type="species:ncbi:10090">mice</span>
###xml 1208 1213 <span type="species:ncbi:10090">mouse</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
###xml 1492 1495 <span type="species:ncbi:40051">BTV</span>
###xml 1608 1614 <span type="species:ncbi:9913">cattle</span>
###xml 1635 1638 <span type="species:ncbi:40051">BTV</span>
###xml 1726 1730 <span type="species:ncbi:10090">mice</span>
###xml 1732 1735 <span type="species:ncbi:40051">BTV</span>
###xml 1799 1804 <span type="species:ncbi:10090">mouse</span>
###xml 1830 1833 <span type="species:ncbi:40051">BTV</span>
###xml 1868 1872 <span type="species:ncbi:10090">mice</span>
###xml 1935 1939 <span type="species:ncbi:10090">mice</span>
###xml 2007 2010 <span type="species:ncbi:40051">BTV</span>
###xml 2023 2026 <span type="species:ncbi:40051">BTV</span>
###xml 2046 2049 <span type="species:ncbi:40051">BTV</span>
###xml 2086 2089 <span type="species:ncbi:40051">BTV</span>
###xml 2135 2141 <span type="species:ncbi:9913">cattle</span>
###xml 2154 2157 <span type="species:ncbi:40051">BTV</span>
###xml 2180 2183 <span type="species:ncbi:40051">BTV</span>
###xml 2212 2216 <span type="species:ncbi:10090">mice</span>
###xml 2228 2231 <span type="species:ncbi:40051">BTV</span>
###xml 2245 2251 <span type="species:ncbi:9913">cattle</span>
###xml 2256 2261 <span type="species:ncbi:9940">sheep</span>
###xml 2278 2281 <span type="species:ncbi:40051">BTV</span>
###xml 2379 2385 <span type="species:ncbi:9913">calves</span>
###xml 2412 2416 <span type="species:ncbi:10090">mice</span>
###xml 2518 2521 <span type="species:ncbi:40051">BTV</span>
###xml 2765 2771 <span type="species:ncbi:9913">calves</span>
###xml 2798 2801 <span type="species:ncbi:40051">BTV</span>
###xml 2834 2838 <span type="species:ncbi:10090">mice</span>
###xml 2865 2868 <span type="species:ncbi:40051">BTV</span>
###xml 2878 2882 <span type="species:ncbi:10090">mice</span>
###xml 3095 3098 <span type="species:ncbi:40051">BTV</span>
###xml 3108 3112 <span type="species:ncbi:10090">mice</span>
###xml 3427 3430 <span type="species:ncbi:40051">BTV</span>
###xml 3458 3461 <span type="species:ncbi:40051">BTV</span>
###xml 3471 3475 <span type="species:ncbi:10090">mice</span>
###xml 3629 3633 <span type="species:ncbi:10090">mice</span>
###xml 3669 3672 <span type="species:ncbi:40051">BTV</span>
###xml 3691 3696 <span type="species:ncbi:10090">mouse</span>
###xml 3747 3750 <span type="species:ncbi:40051">BTV</span>
Up-regulation of type I IFN is one of the earliest cellular responses upon contact with infectious agents. The rapid induction of type I IFN reflects the crucial role that this cytokine plays in the inhibition of viral spread before the generation of a specific immune response. Given that viruses must at least partially circumvent the IFN response, it is not surprising that an inability to do this can restrict host range. There are many examples where this is known. For example, neither measles virus nor polio virus will replicate efficiently in mouse models unless the IFN system has been compromised [24], [31]. BTV is a potent type I interferon inducer in mice and cattle [14], [16], [32]. Our results show that BTV is pathogenic for IFNAR(-/-) mice mainly due to the lack of the IFN-I receptor, allowing the virus to circumvent the IFN-I response in the host. In addition, IFNAR(-/-) mice serve as a good animal model for BTV, reproducing many aspects of its natural host infection. First, IFNAR(-/-) mice infected with BTV showed viremia and disease symptoms, in contrast with C57BL/6 mice, which did not show them, even when these animals were infected at the highest viral dose tested (106 PFUs/mouse). The appearance of viremia after inoculation in infected IFNAR(-/-) mice was dependent on the viral dose, althought the highest titers observed in blood were not dose-dependent. Second, the differential virulence of serotypes 4 and 8 were maintained in this animal model. Some BTV serotypes such as serotype 8, which recently caused infection in northern Europe, exhibit enhanced virulence in cattle [5], in contrast to BTV-4 that usually exhibits subclinical infections in this species. In infected IFNAR(-/-) mice, BTV-8 killed 100% of the animals with a dose as low as 10 PFUs per mouse. In contrast 103 PFUs of BTV-4 were needed to kill 100% of the mice. In addition, the virus titers found in the blood of infected mice were similar at the same virus doses for the animals infected with BTV-8 than with BTV-4, indicating that BTV-8 exhibited a higher virulence than BTV-4 in the IFNAR(-/-) model, as is observed in cattle, one of the BTV natural hosts. Third, BTV dissemination in IFNAR(-/-) mice reproduced BTV infection in cattle and sheep. High titers of BTV are present in the lungs, precapsular and mesenteric lymph nodes, thymus, and spleen of infected calves [33], [34]. In IFNAR(-/-) mice, the virus was detected in spleen before was isolated from other organs, including blood. Release of BTV from spleen was followed by an increased in viremia and dissemination to other organs (lymph nodes, lung and thymus), followed by its dissemination to lymph nodes, lung, and thymus after intravenous infection. This has been suggested also for calves [34] indicating a similar BTV spreading pattern in IFNAR(-/-) mice. Histological analyses of BTV infected mice at 48 h.p.i. showed many similarities with lessions described in natural hosts. The permeability disorders of the vascular system described for ruminants [35] is reflected in the petecheias observed in spleen in BTV infected mice. The enlargement of lymph nodes reflects an ongoing immune response. However, the observed lymphoid depletion suggests that other cells are migrating to these organs or that a general aedema results in organ enlargement. The lungs are especially susceptible to permeability disorders of the vasculature induced by BTV, and this is consistent in BTV infected mice as well as in ruminants. In general, pathology in natural hosts has not been profoundly studied. The described pathology similarities between IFNAR(-/-) mice and ruminants after infection with BTV indicate that our mouse model may be a good tool to study new findings in BTV pathology.
###end p 36
###begin p 37
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Franchi1">[28]</xref>
###xml 326 331 326 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Muller1">[20]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Fiette1">[22]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Ohka1">[24]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Ohno1">[25]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Bouloy1">[26]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Waibler1">[27]</xref>
###xml 593 598 593 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 958 963 958 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 1476 1477 1476 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1730 1734 1730 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Paradell1">[36]</xref>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 172 175 <span type="species:ncbi:40051">BTV</span>
###xml 274 277 <span type="species:ncbi:40051">BTV</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 374 377 <span type="species:ncbi:40051">BTV</span>
###xml 684 687 <span type="species:ncbi:40051">BTV</span>
###xml 775 778 <span type="species:ncbi:40051">BTV</span>
###xml 938 941 <span type="species:ncbi:40051">BTV</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1000 1003 <span type="species:ncbi:40051">BTV</span>
###xml 1185 1188 <span type="species:ncbi:40051">BTV</span>
###xml 1238 1241 <span type="species:ncbi:40051">BTV</span>
###xml 1276 1280 <span type="species:ncbi:10090">mice</span>
###xml 1287 1290 <span type="species:ncbi:40051">BTV</span>
###xml 1445 1449 <span type="species:ncbi:10090">mice</span>
###xml 1517 1521 <span type="species:ncbi:10090">mice</span>
###xml 1654 1660 <span type="species:ncbi:9913">cattle</span>
###xml 1665 1670 <span type="species:ncbi:9940">sheep</span>
###xml 1694 1697 <span type="species:ncbi:40051">BTV</span>
###xml 1712 1715 <span type="species:ncbi:40051">BTV</span>
###xml 1785 1788 <span type="species:ncbi:40051">BTV</span>
###xml 1874 1879 <span type="species:ncbi:10090">mouse</span>
###xml 1988 1992 <span type="species:ncbi:10090">mice</span>
The cost of testing new vaccines in target species is a major obstacle for laboratories and industries. For this reason, the intracerebral inoculation of newborn mice with BTV vaccines has been used as an animal model to evaluate the level of attenuation of live attenuated BTV vaccines [28]. Our results show that adult IFNAR(-/-) mice serve as a good animal model to test BTV vaccines. Even though the lack of type I interferon signals may have an effect in the development of acquired immune responses, our results and previous studies [20], [22], [24], [25], [26], [27] show that the IFNAR(-/-) infection model is useful for the definition of effective vaccine candidates against BTV. Indeed, in our study all immunized animals developed an antibody response specific of BTV-4 with the production of neutralizing antibodies against the same serotype, indicating a successful immunization. The protection mediated by inactivated whole BTV vaccine in IFNAR(-/-) mice infected with a lethal dose of BTV-4 was complete, and 100% of the animals did not show any symptoms associated with infection or died. Viremia was not detected in the blood of immunized animals after challenge with BTV-4 when analyzed by plaque assay. The presence of BTV genomes in the blood of immunized mice after BTV-4 challenge analyzed by RT-qPCR, a more sensible method than the plaque assay, showed the presence of viral genomes in the blood of some of the immunized mice but in all the cases, the Cts were higher than in the nonimmunized mice and those that were RT-qPCR positive reverted to negative at day seven post-challenge. Similar RTqPCR results have been observed in cattle and sheep vaccinated with ZULVAC-BTV-4 inactivated BTV-4 preparation [36] These results strongly support the involvement of BTV in the pathological processes described in this work and, moreover, suggest that the mouse model is adequate to evaluate vaccine candidates. Future work will determine whether the ability to protect mice with other vaccine formulations mimics the capacity to protect the natural host.
###end p 37
###begin p 38
###xml 93 98 93 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 65 68 <span type="species:ncbi:40051">BTV</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 242 245 <span type="species:ncbi:40051">BTV</span>
###xml 327 330 <span type="species:ncbi:40051">BTV</span>
In summary, we have characterized a novel small animal model for BTV infection based on IFNAR(-/-) adult mice that reproduces many aspects of its natural host infection. This animal model may facilitate the understanding of the mechanisms of BTV pathogenicity in its natural host and a faster advance in the development of new BTV vaccines.
###end p 38
###begin title 39
Materials and Methods
###end title 39
###begin title 40
Virus and cells
###end title 40
###begin p 41
###xml 153 157 <span type="species:ncbi:9913">calf</span>
###xml 227 230 <span type="species:ncbi:40051">BTV</span>
###xml 311 316 <span type="species:ncbi:9940">sheep</span>
###xml 340 344 <span type="species:ncbi:9913">calf</span>
Baby hamster kidney cells (BHK-21), and Vero cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2mM glutamine and 10% fetal calf serum (FCS). Standard virus titrations were performed in Vero cells. BTV serotypes 4 (Spain/01) and 8 (Belgium/06), originally isolated from an infected sheep in Spain in 2001 and a calf in Belgium in 2006, respectively, were used in the experiments. Virus stocks were generated by infection of confluent BHK-21 cells using a multiplicity of infection (MOI) of 1. At 48 h.p.i. or when total cytopathic efect (CPE) was visible, the cells and supernatants were harvested and centrifuged. The virus was released from the cells by three freeze and thaw cycles.
###end p 41
###begin title 42
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 42
###begin p 43
###xml 79 82 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o/o</sup>
###xml 88 93 81 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 99 103 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Muller1">[20]</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">Mice</span>
C57BL/6 mice were purchased from Harlan Interfauna Iberica S.L. IFN alpha/betaRo/o IFNAR(-/-) mice [20], on a C57BL/6 genetic background, were generously provided by Professor R. Zinkernagel (Institute of Experimental Medicine, Zurich). All mice used were matched for sex and age (males 8 weeks). Mice were maintained under pathogen-free conditions and allowed to acclimatize to the biosafety level 3 (BSL3) animal facility at the Centro de Investigacion en Sanidad Animal, INIA, Madrid, for 1 week before use in our experiments. All experiments with live animals were performed under the guidelines of the European Community (86/609) and were approved by the site ethical review committee.
###end p 43
###begin title 44
Animal inoculation and processing of samples
###end title 44
###begin p 45
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Reed1">[37]</xref>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 64 68 <span type="species:ncbi:10090">Mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
Mice were infected intravenously with different doses of virus. Mice were examined for clinical symptoms daily. LD50 values were calculated by the method of Reed and Muench (1938) [37], after inoculation of mice with 10-fold serial dilutions of virus (from 106 to 101 PFU/mouse). Whole blood was collected in EDTA from all animals at regular intervals after inoculation. At varying times post-infection, several mice were sacrificed by perfusion with phosphate-buffered saline (PBS), and several organs (spleen, lung, thymus, liver, brain, heart, tongue, skin, and testicles), and lymph nodes (popliteal, inguinal, mediastinal, and mesenteric) were harvested. Tissues were homogenized in PBS using a Tissue Lyser homogenizer (Quiagen). The viruses were released from whole blood and homogenized tissues by three freeze/thaw cycles. The amount of infectious virus was measured by plaque assay on Vero cells.
###end p 45
###begin title 46
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine immunizations
###end title 46
###begin p 47
###xml 17 22 17 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;/&#8722;)</sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 122 124 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 103 106 <span type="species:ncbi:40051">BTV</span>
###xml 143 146 <span type="species:ncbi:40051">BTV</span>
###xml 267 271 <span type="species:ncbi:10090">Mice</span>
###xml 319 322 <span type="species:ncbi:40051">BTV</span>
###xml 376 380 <span type="species:ncbi:10090">Mice</span>
###xml 458 461 <span type="species:ncbi:40051">BTV</span>
Groups of 6 IFNAR(-/-) mice were immunized by two consecutive subcutaneous injections of either ZULVAC-BTV-4 (1.5x106 TCID50BTV-4) inactivated BTV-4 preparation (Fort Dodge Veterinaria, S.A.) or phosphate-buffered saline (PBS) (controls), administered 3 weeks apart. Mice were intravenously inoculated with 103 PFUs of BTV-4 (lethal dose) 3 weeks after the last immunization. Mice were bled before each immunization and virus challenge. Sera were tested for BTV-4 neutralizing antibodies by Virus Neutralization Test (VNT).
###end p 47
###begin title 48
Histopathology
###end title 48
###begin p 49
Samples from different tissues and organs were taken and fixed in 10% buffered formalin (pH 7.2) for histopathological studies. After fixation, samples were dehydrated through a graded series of alcohol to xylol and embedded in paraffin wax. Sections of 4-im-thick were cut and stained with hematoxylin and eosin (H & E) for histopathological analyses.
###end p 49
###begin title 50
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
BTV-VP2 antibody detection by indirect ELISA
###end title 50
###begin p 51
###xml 723 724 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 726 727 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
MaxiSorp plates (Nunc, USA) were coated with VP2 baculovirus expressed protein (164 ng per well) and incubated overnight at 4degreesC. Plates were saturated with blocking buffer (PBS-0.05% Tween 20 and 5% skimmed milk). The animal sera, diluted in blocking buffer were added and incubated for 1 hour at 37degreesC. After three washes in PBS-0.05% Tween 20, plates were incubated for 1 hour at 37degreesC with an anti-mouse-HRP secondary antibody (Biorad, USA) at a 1/2,000 dilution in blocking buffer. Finally, after three washes in PBS-0.05% Tween 20, the reaction was developed with 50 microl of substrate solution 3,3', 5,5'-tetramethylbencidine liquidsupersensitive (TMB) (Sigma) and stopped by adding 50 microl of 3N H2SO4. Results were expressed as optical densities (ODs) measured at 450 nm.
###end p 51
###begin title 52
###xml 0 3 <span type="species:ncbi:40051">BTV</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
BTV-4 neutralizing antibody detection in immunized mice by virus neutralizing test (VNT)
###end title 52
###begin p 53
###xml 67 70 <span type="species:ncbi:40051">BTV</span>
###xml 155 158 <span type="species:ncbi:40051">BTV</span>
The VNT was used to determine neutralizing antibody titers against BTV-4. For plaque reduction assays, 2 fold dilutions of sera were mixed with 100 PFU of BTV-4, incubated for 1 hour at 37degreesC and then plated onto monolayers of Vero cells. After 1 hour, agar overlays were added and the plates were incubated for 5 days. The titer was determined as the highest dilution that reduced the number of plaques by 50%.
###end p 53
###begin title 54
###xml 21 24 <span type="species:ncbi:40051">BTV</span>
RT-qPCR specific for BTV segment 5
###end title 54
###begin p 55
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005171-Toussaint1">[38]</xref>
###xml 94 97 <span type="species:ncbi:40051">BTV</span>
###xml 272 275 <span type="species:ncbi:40051">BTV</span>
Whole blood was collected in EDTA from all animals at regular intervals after inoculation and BTV challenge. Total RNA was extracted from blood with TRI Reagent Solution (Ambion), according to the method recommended by the manufacturer. The real-time RT-qPCR specific for BTV segment 5 was performed as described by Toussaint et al. (2007) [38].
###end p 55
###begin p 56
###xml 56 59 <span type="species:ncbi:40051">BTV</span>
###xml 87 90 <span type="species:ncbi:40051">BTV</span>
We thank Fort Dodge Veterinaria SA for facilitating the BTV inactivated vaccine ZULVAC-BTV-4.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
###xml 11 24 <span type="species:ncbi:198116">biting midges</span>
Culicoides biting midges: their role as arbovirus vectors.
###end article-title 58
###begin article-title 59
###xml 26 42 <span type="species:ncbi:40051">bluetongue virus</span>
Molecular epidemiology of bluetongue virus in Portugal during 2004-2006 outbreak.
###end article-title 59
###begin article-title 60
###xml 26 42 <span type="species:ncbi:40051">bluetongue virus</span>
Molecular epidemiology of bluetongue virus serotype 4 isolated in the Mediterranean Basin between 1979 and 2004.
###end article-title 60
###begin article-title 61
###xml 0 16 <span type="species:ncbi:40051">Bluetongue virus</span>
Bluetongue virus in the Mediterranean Basin 1998-2001.
###end article-title 61
###begin article-title 62
Bluetongue epidemiology in the European union.
###end article-title 62
###begin article-title 63
Climate change and the recent emergence of bluetongue in Europe.
###end article-title 63
###begin article-title 64
###xml 4 20 <span type="species:ncbi:40051">bluetongue virus</span>
The bluetongue virus core: a nano-scale transcription machine.
###end article-title 64
###begin article-title 65
###xml 40 56 <span type="species:ncbi:40051">bluetongue virus</span>
Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.
###end article-title 65
###begin article-title 66
###xml 20 36 <span type="species:ncbi:40051">bluetongue virus</span>
Characterization of bluetongue virus ribonucleic acid.
###end article-title 66
###begin article-title 67
###xml 17 33 <span type="species:ncbi:40051">bluetongue virus</span>
Structure of the bluetongue virus capsid.
###end article-title 67
###begin article-title 68
###xml 66 82 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Sequential distribution of neurovirulent and avirulent strains of bluetongue virus in neonatal mice by RT-PCR.
###end article-title 68
###begin article-title 69
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 31 36 <span type="species:ncbi:9940">sheep</span>
###xml 45 61 <span type="species:ncbi:40051">bluetongue virus</span>
Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody.
###end article-title 69
###begin article-title 70
###xml 36 52 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Growth of a neuroinvasive strain of bluetongue virus in suckling mice.
###end article-title 70
###begin article-title 71
###xml 0 16 <span type="species:ncbi:40051">Bluetongue virus</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Bluetongue virus, an exceptionally potent interferon inducer in mice.
###end article-title 71
###begin article-title 72
###xml 24 30 <span type="species:ncbi:9913">bovine</span>
###xml 69 85 <span type="species:ncbi:40051">bluetongue virus</span>
Interferon induction in bovine and feline monolayer cultures by four bluetongue virus serotypes.
###end article-title 72
###begin article-title 73
###xml 0 16 <span type="species:ncbi:40051">Bluetongue virus</span>
###xml 39 45 <span type="species:ncbi:9913">cattle</span>
Bluetongue virus-induced interferon in cattle.
###end article-title 73
###begin article-title 74
###xml 82 87 <span type="species:ncbi:9940">sheep</span>
###xml 110 126 <span type="species:ncbi:40051">bluetongue virus</span>
Temporal relationships of viremia, interferon activity, and antibody responses of sheep infected with several bluetongue virus strains.
###end article-title 74
###begin article-title 75
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.
###end article-title 75
###begin article-title 76
Interferon-induced proteins and the antiviral state.
###end article-title 76
###begin article-title 77
Functional role of type I and type II interferons in antiviral defense.
###end article-title 77
###begin article-title 78
Interferon-induced antiviral actions and their regulation.
###end article-title 78
###begin article-title 79
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors.
###end article-title 79
###begin article-title 80
###xml 80 90 <span type="species:ncbi:138953">poliovirus</span>
The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.
###end article-title 80
###begin article-title 81
###xml 19 29 <span type="species:ncbi:138953">poliovirus</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 61 71 <span type="species:ncbi:138953">poliovirus</span>
###xml 92 107 <span type="species:ncbi:10090">transgenic mice</span>
Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor.
###end article-title 81
###begin article-title 82
###xml 0 13 <span type="species:ncbi:11234">Measles virus</span>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection.
###end article-title 82
###begin article-title 83
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.
###end article-title 83
###begin article-title 84
###xml 9 30 <span type="species:ncbi:126794">vaccinia virus Ankara</span>
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
###end article-title 84
###begin article-title 85
###xml 60 76 <span type="species:ncbi:40051">bluetongue virus</span>
Laboratory tests for evaluating the level of attenuation of bluetongue virus.
###end article-title 85
###begin article-title 86
###xml 51 67 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection.
###end article-title 86
###begin article-title 87
###xml 77 93 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Effects of viral infection on nervous system development. I. Pathogenesis of bluetongue virus infection in mice.
###end article-title 87
###begin article-title 88
###xml 0 13 <span type="species:ncbi:11234">Measles virus</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Measles virus spread and pathogenesis in genetically modified mice.
###end article-title 88
###begin article-title 89
###xml 29 45 <span type="species:ncbi:40051">bluetongue virus</span>
Induction of interferon with bluetongue virus in various cells.
###end article-title 89
###begin article-title 90
###xml 33 49 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 63 69 <span type="species:ncbi:9913">calves</span>
The pathogenesis of experimental bluetongue virus infection of calves.
###end article-title 90
###begin article-title 91
###xml 28 44 <span type="species:ncbi:40051">bluetongue virus</span>
###xml 54 60 <span type="species:ncbi:9913">calves</span>
Dynamics of viral spread in bluetongue virus infected calves.
###end article-title 91
###begin article-title 92
###xml 0 16 <span type="species:ncbi:40051">Bluetongue virus</span>
Bluetongue virus: virology, pathogenesis and immunity.
###end article-title 92
###begin article-title 93
###xml 68 84 <span type="species:ncbi:40051">bluetongue virus</span>
Efficacy of ZULVAC(R) 1 -inactivaded and adjuvanted vaccine against bluetongue virus serotype 1.
###end article-title 93
###begin article-title 94
A simple method of estimating fifty percent endpoints.
###end article-title 94
###begin article-title 95
###xml 0 16 <span type="species:ncbi:40051">Bluetongue virus</span>
Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments.
###end article-title 95
###begin p 96
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 96
###begin p 97
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Institute of Agronomics Research (INIA) (RTA-2006-169), the Comision Interministerial de Ciencia y Tecnologia (CICYT) (AGL2008-00646/GAN), and the EU Network of Excellence EPIZONE (Contract No FOOD-CT-2006-016236). Eva Calvo-Pinilla and Teresa Rodriguez-Calvo received fellowships from INIA and Comunidad de Madrid, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 97

